Aurobindo Pharma shares rise 0.6% as Nifty drops

Synopsis

The stock quoted a 52-week high price of Rs 730.0 and a 52-week low of Rs 397.3.

Stock-market-4---istockAgencies
Mazhar Mohammad of Chartviewindia.in said technical indicators are turning mixed as the weekly MACD chart has generated a 'buy' signal, giving an edge to the bulls.
Shares of Aurobindo Pharma Ltd. traded 0.6 per cent up at Rs 460.35 on Tuesday at around 11:07AM (IST), while the benchmark BSE Sensex declined 70.17 points to 59218.18.

As many as 12,301 shares changed hands on the counter with a total value of Rs 0.57 crore.

The stock quoted a 52-week high price of Rs 730.0 and a 52-week low of Rs 397.3.

On the technical charts, the 200-DMA of the stock stood at Rs 504.61, while 50-DMA was at Rs 443.81. If a stock trades above 50 DMA and 200 DMA, it usually means the immediate trend is up. On the other hand, if the stock trades below 50 DMA and 200 DMA both, it is considered a bearish trend and if it trades between 50DMA and 200DMA, then it suggests the stock can go anywhere.

Shares of the company have advanced 26.4 per cent in the past one year, while Sensex has risen 6.01 per cent during the same period.

According to BSE data, the stock trades at a price-to-earnings multiple of 13.45 and a price-to-book ratio of 1.59. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price to book value indicates the inherent value of a company and reflects the price that investors are ready to pay even for no growth in a business. The stock belongs to the Pharma - Indian industry.
Experience Your Economic Times Newspaper, The Digital Way!

Read More News on

(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

...more
Pick the best stocks for yourself
Powered by